Product Reports Resources Pricing Login Book a demo

NURX

Health Tech & Medtech · San Francisco, United States · Founded 2015

Telemedicine platform focused on birth control and HIV prevention MoreLess

Nurx operates in the telehealth sector, offering a convenient and affordable way for individuals to access healthcare services online. The company primarily serves clients who require birth control, genital herpes treatment, and other prescription medications. Nurx's business model revolves around connecting patients with licensed medical professionals who can prescribe medications and provide guidance without the need for in-person visits. The company generates revenue through the sale of prescription medications and home testing kits, which are delivered directly to the client's door. Nurx also offers automatic refills and renewals, ensuring continuous coverage for their clients. The market Nurx operates in includes individuals seeking accessible and cost-effective healthcare solutions, particularly those who may not have easy access to traditional healthcare services or prefer the convenience of online consultations. The company aims to make healthcare easy, affordable, and accessible, with or without insurance coverage.

Keywords: telehealth, birth control, genital herpes, prescriptions, home testing kits, online healthcare, automatic refills, affordable, accessible, licensed doctors.

Company overview

NURX company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2015
Headquarters
San Francisco, United States
Employees
113
Open positions
None listed
Dealroom signal
65.0
Investment activity
1 companies · latest Feb 2022
Capital deployed
Preferred round
MERGER
sub industryHealth PlatformsectorPersonal HealthindustryHealthsectorPharmacysectorDirect-to-ConsumersectorSustainable Development GoalssectorSextechsectorTech for PatientssectorHard TechsectorYC W16client focusb2c

Valuation & funding

NURX funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
MERGEROther financing Feb 2022 $0 Thirty Madison
SERIES COther financing Aug 2020 $23M $268M Union Square Ventures · Trustbridge · Trustbridge Partners · Kleiner Perkins
SERIES COther financing Aug 2019 $32M $268M Union Square Ventures · Kleiner Perkins · Lowercase Capital
SERIES BOther financing Jul 2018 $36M $144M Union Square Ventures · Lowercase Capital · Y Combinator · Kleiner Perkins
SERIES BOther financing Dec 2017 $0 Liquid 2 Ventures
SERIES AOther financing Oct 2016 Kevin Patrick Mahaffey · Matt Mazzeo · Fifty Years · #Angels
SEEDOther financing Mar 2016 Y Combinator
SEEDOther financing Nov 2015 Y Combinator · Panos Papadopoulos
SEEDOther financing Jan 2015 Undisclosed
Showing 9 recorded eventsUnlock the complete deal history →

Growth signals

NURX website traffic

Latest recorded traffic for NURX is 1.1M monthly website visits, up 10% over the last three months. NURX's team declined 8.9% over the past year.

Latest monthly visits1.1M 3-month web change+10% 1-year team growth-8.9%
Monthly website visits124 observations · Apr 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

NURX compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

NURX's talent

Book a demo to see the people
Team profiled 34 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

15 investors on NURX's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
Y Combinator
Panos Papadopoulos
Series B+ 4 investors entered at this stage
Trustbridge Partners
Comcast Ventures
Wittington Ventures
Trustbridge
Other known 1 additional known investor
Thirty Madison

Global footprint

Where NURX has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States95.8%
🇪🇬 Egypt1.4%
🇨🇦 Canada1.4%
3 countries shown

In the news

Latest news about NURX

Recent press, funding announcements, and product moves mentioning NURX — open to read from the original sources.

See all news

Market sentiment

What the market is saying about NURX

An AI-synthesized read of the highest-engagement posts about NURX on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NURX’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.